Delivery Order SPE2DR25D2206-SPE2DR26F9DS5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on November 6, 2025, with a ceiling value of $1,092.57. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made on a competitive, non-set-aside basis and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Valtoco 5 mg nasal sprays, with a ceiling value of $1,384.85 and a completion date of December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $2,259.24 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Valtoco is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on October 23, 2025, with a ceiling value of $1,823.55 and firm fixed pricing. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by October 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Valtoco 5 mg nasal sprays, with a ceiling value of $5,028.35. This competitively awarded, firm fixed-price delivery order is set to conclude by September 12, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Valtoco 10 mg nasal spray in a 5-pack unit configuration. This competitively awarded, non-set-aside contract carries a ceiling value of $3,388.86 under firm fixed pricing terms, with ultimate completion scheduled for June 27, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,197.63 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger contract vehicle with the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Valtoco 15 mg nasal spray, a medication used for acute seizure management. This firm fixed-price delivery order, valued at $3,385.62, represents a non-competitive set-aside contract and is scheduled for completion by July 24, 2025. The award was issued from the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,462.43 to AmerisourceBergen Drug Corp for the supply of Valtoco 20 mg nasal sprays. This firm fixed price delivery order, issued on November 13, 2025, with a completion date of November 14, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,022.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Valtoco 10 mg nasal sprays, with final delivery required by December 4, 2025. The award is non-set-aside and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9DS5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Valtoco 5 mg nasal spray with a ceiling value of $4,818.32. This competitively awarded, firm fixed-price contract is scheduled for completion by December 2, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement that enables the company to deliver a broad range of medications and medical supplies to support military healthcare programs globally. Valtoco is an emergency medication used for acute seizure management, aligning with the company's extensive portfolio of specialty pharmaceuticals supplied to the Defense Health Agency and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen routinely fulfills such orders through its established DLA framework, which covers medications across multiple therapeutic domains including neurological, pain management, diabetes, and infectious disease treatments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 11/30/25 |